← Leaderboards
Victoria Ahn
Confometrx, Inc.
$817,454
Attributed
$2,355,518
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $764.5K · FY2017–21$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$2,355,518 · 2
By mechanism
R44$2,161,833 · 1
R43$193,685 · 1
Top collaborators
- Inbar Fish3 shared
- Bingfa Sun3 shared
- Dan Feng1 shared
Most similar at Confometrx, Inc.
Same institution · by research overlap
- Bingfa Sun$4,003,184
- Dan Feng$2,524,550
- Inbar Fish$1,649,318
- Matthew Chu$124,502
Others in their field
Other Emerging Leaders on “Ligands”
- John Damon Chodera · Sloan-Kettering Inst Can Research$39,009,297
- Jay Evans · University Of Montana$23,628,886
- Alan D. Palkowitz · Indiana University Indianapolis$21,600,744
- Bryan Roth · Univ Of North Carolina Chapel Hill$21,325,531
- Xinhua Li · Nano Terra, Inc.$11,962,715
- Gregory L Hura · University Of Calif-Lawrenc Berkeley Lab$10,638,609
Research focus
LigandsNeuraxisFunding OpportunitiesLeadMedicineAntipsychotic AgentsDrug Of AbuseFunctional DisorderDopamine D2 ReceptorG-Protein-Coupled ReceptorsDrug AddictionAffectCenters For Disease Control And Prevention (U.S.)Central Nervous System DiseasesDopamine ReceptorDrug DiscoveryBaseDesignBehaviorAgonistBindingDopamineBrainNeurotransmission
Grant awards (4)
Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands$738,119
R44 · FY2021 · MH · contact PI
Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands$764,531
R44 · FY2020 · MH · contact PI
Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands$659,183
R44 · FY2019 · MH · contact PI
Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands$193,685
R43 · FY2017 · MH · contact PI